Navigation Links
Drugs of Abuse Urine Screen Control

ProductsDrugs of Abuse Urine Screen Control
Company Quantimetrix Corporation
Item Drugs of Abuse Urine Screen Control
Features 
  • Two screening cut-off levels for opiates Level 3/300 (300 ng/mL) and Level 3/2000 (2000 ng/mL)
  • Liquid, human urine-based
  • 3 year unopened and open vial stability when stored at 2-8 C*

    *from date of manufacture

Description This control monitors the performance of Abuscreen ONLINE, AxSYM, EMIT, Triage, and other drugs of abuse screening methods. This control meets current revised guidelines established by the Substance Abuse and Mental Health Services Administration (SAMSHA). Level 1 is drug free urine. Level 2 has drug analytes below screening cut-off levels (negative threshold screen). Level 3 is designed to contain drug analytes above screening cut-off levels (positive screen).
Info Quantimetrix Corporation
Customer Service: (800) 624-8380
Web site: http://www.4qc.com/

Related medicine products :

1. Triage® Drugs of Abuse Panels
2. Drugs of Abuse Array Cocaine Metabolite Assay
3. Drugs of Abuse Array Evidence Opiates Assay
4. Drugs of Abuse Array Evidence Methodone Assay
5. Drugs of Abuse Array Evidence Ampphetimine Assay
6. Drugs of Abuse Array Evidence Barbiturates Assay
7. Drugs of Abuse Array Evidence Ampphetimine
8. Drugs of Abuse Array Evidence Cannabiniods Assay
9. Drugs of Abuse Array Evidence Phencyclidine Assay
10. Drugs of Abuse Array Evidence Benzodiazpine Class Assay
11. Sota Omoiguis Anesthesia Drugs Handbook
Derived from an extensive study into increasing the range of motion in hip replacement, the cemented SHP acetabular cup is a unique design and is manufactured from ArCom polyethylene.
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects.
Duraloc 400 series cup.
The Trident PSL Acetabular Shells are designed to maximize fixation in the peripheral lunate region of the acetabulum.
Medicine Products:
(Date:7/4/2009)...alth and fitness need not suffer, , , S...e cutting back in these tough economic times, tryi... cut back when it comes to your health? , As it... about it. There are ways to save money, they say,...fit and receiving needed medical care. , Healt...
(Date:7/3/2009)...- Bertalan Mesko, medical blogger and health 2.0 c...l professionals focusing on how the virtual worlds...expensive and patients are also open to use virtua...s enter a virtual realm and organize medical prese...ides opportunities for case presentations, e-learn...
(Date:7/3/2009)...e/ -- Republicans on the Senate Finance Committee ...islation that would eliminate coverage for abortio... coverage for abortion services that their private...ninsured women will still lack a basic health care...lity of life. , , If these senators are allowed...
(Date:7/3/2009)...unches new content to include information about hi...t deal with these health issues. , ...verseAges.com has recently launched a new series o... health issues such as high blood pressure. High b...nd the new content on ReverseAges.com addresses th...
Breaking Medicine News(10 mins):Health News:Living Healthily on Less 2Health News:Living Healthily on Less 3Health News:Living Healthily on Less 4
...on and floods occur through out the country,Water ...ing the workshop on 'water microbiology' stressed ...rm their purity, as water supplies were contaminat...imal excreta. The workshop was inaugurated by Dr ...
...ffecting almost one-tenth of the population over a...so treatment is aimed at improving patients' quali...Acupuncture in addition to drug treatment for oste... treatment alone, shows new research out of Spain....
...cancer risk in men, but not in women, say research...cted a study on 13,017 French adults. The particip...le containing 120 milligrams of ascorbic acid (vit... milligrams of beta carotene, 100 micrograms of se...
...apy in addition to medication show an improved cli...d with medication, according to a new study. Resea...chemic stroke due to a blockage in the middle cere...ed with tissue plasminogen activator (t-PA) within...
Other Medicine News:
(Date:7/1/2009)... , REYKJAVIK, Iceland, July 1 /PRNewswire-F... schizophrenia ever undertaken has revealed severa...ce of the human genome (SNPs) linked to,risk of t...um of scientists,led by a team from deCODE geneti... than 50,000 patients and control participants fro...
(Date:6/30/2009)... , FRAZER, Pa., June 30 /PRNewswire-FirstCall/ ...d that it has submitted a supplemental New Drug Ap...tration (FDA) requesting approval of NUVIGIL(R) (a...mproved wakefulness in patients with excessive sle... from eastbound travel. Jet lag disorder is an ac...
(Date:6/29/2009)... , Study in major abdominal surgery patients ac...OOD CITY, Calif., June 29 AcelRx P...lts from the second Phase 2 clinical study evaluat...il NanoTabs(TM) for the management of acute post-o...ia during hospitalization. Compared to placebo, pa...
(Date:6/28/2009)... , CHIPPENHAM, England and TOKYO, June 29 /...estones for Both Companies , Sosei Group Co...ectura,Group plc ("Vectura"; LSE: VEC) announce t...Novartis, with NVA237, a once-daily, long-acting m...chronic obstructive pulmonary disease,(COPD). NVA...
Breaking Medicine Technology:deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 4deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 5Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 4AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4Study finds rescue course of antenatal steroids improves outcome in premature babies 6843 1Study finds rescue course of antenatal steroids improves outcome in premature babies 6843 2Alliance of Experts Created to Help Raise Awareness of Best Practices in Diabetes Treatment 35172 1Alliance of Experts Created to Help Raise Awareness of Best Practices in Diabetes Treatment 35172 2Alliance of Experts Created to Help Raise Awareness of Best Practices in Diabetes Treatment 35172 3Health Integrated Achieves NCQA Full Accreditation for Its Synergy Targeted Population Management 28TM 29 Program 35170 1Health Integrated Achieves NCQA Full Accreditation for Its Synergy Targeted Population Management 28TM 29 Program 35170 2Today Show and American Legacy Foundation 28R 29 Team Up to Help Smokers Call it Quits 35169 1Today Show and American Legacy Foundation 28R 29 Team Up to Help Smokers Call it Quits 35169 2Today Show and American Legacy Foundation 28R 29 Team Up to Help Smokers Call it Quits 35169 3Today Show and American Legacy Foundation 28R 29 Team Up to Help Smokers Call it Quits 35169 4Today Show and American Legacy Foundation 28R 29 Team Up to Help Smokers Call it Quits 35169 5
... Calif., April 18, 2007,/PRNewswire-FirstCall/ -- ... data from a preclinical study in which BiTE(R) mo...ere shown to prevent,subcutaneous tumor growth and...er for tumor progression, CEA is frequently,expres...hese data,presented yesterday in a poster session...
...r 19, 2007 - Antares Pharma, Inc.,(AMEX: AIS) anno...ite application study demonstrating that ANTUROL(R...sorbed on a bioequivalent,basis after a single-dos...ns., The study was an open-label, comparative thre...study. The trial enrolled 25,healthy subjects (80%...
Other Medicine Technology:Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 2Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 3Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 4Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 5Antares Pharma Announces Positive Results from Application Site,Study for Anturol 2Antares Pharma Announces Positive Results from Application Site,Study for Anturol 3